AI assistant
Sending…
CATALYST PHARMACEUTICALS, INC. — Director's Dealing 2019
Oct 11, 2019
31542_dirs_2019-10-11_4d3b07a9-3845-4fe4-bbaa-277dd0c755b1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CATALYST PHARMACEUTICALS, INC. (CPRX)
CIK: 0001369568
Period of Report: 2019-10-11
Reporting Person: O'Keeffe Charles B (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-10-11 | Common stock, par value $0.001 per share | P | 10000 | $4.695 | Acquired | 553376 | Direct |
More from CATALYST PHARMACEUTICALS, INC.
M&A Activity
2026
Jun 8
Report Publication Announcement
2026
May 11
M&A Activity
2026
May 7
Major Shareholding Notification
2026
Mar 26
Earnings Release
2026
Feb 25
Annual Report
2026
Feb 25
Director's Dealing
2026
Feb 19
Investor Presentation
2026
Jan 12
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6